期刊文献+

mRNA前体选择性剪接的研究进展 被引量:4

Progress in the study of alternative splicing of pre-mRNA
下载PDF
导出
摘要 mRNA前体的选择性剪接(又称可变剪/拼接)是真核生物的一种基本而又重要的调控机制;它精细协调基因的功能;高效调节基因的定量表达以及蛋白功能的多样化,影响主要发育方向的决定,对细胞的分化、发育、生理功能和病理状态都有重要意义。选择性剪接与许多人类疾病密切相关。目前在生物信息学领域已有选择性剪接数据库的构建,用于选择性剪接的信息存储和处理。 Alternative splicing of pre-mRNA is a powerful and versatile regulatory mechanism used in the eukaryotes that can effect quantitative control of gene expression and functional di-versification of proteins. It contributes to major developmental decisions and also to fine tuning of gene function. Often regulated in specific spatial/temporal patterns , it plays a major role in the physiology and pathology of a major cellular events in those developmental stage specific processes. Alternative splicing is closely connected with many human diseases.The Alternative Splicing database (ASDB) has been established with the intention of assembling in a central, pub-licly accessible site information about alternatively spliced genes, their products and expression patterns.
出处 《生命科学》 CSCD 2002年第3期150-152,185,共4页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金资助项目(30170053 30170833)
关键词 MRNA前体 选择性剪接 研究进展 Key words: pre-mRNA alternative splicing development
  • 相关文献

参考文献13

  • 1Modrek B, Resch A, Grasso C, et al. Nucleic Acids Research, 2001; 29(13): 2850-2859.
  • 2Dralyuk I, Brudno M, Gelfand M S, et al. Nucleic Acids Research, 2000; 28(1): 296-297.
  • 3van der Houven van Oordt W, Diaz-Meco M T,Lozano J, et al. J Cell Biol, 1999; 149: 307-316.
  • 4Sugino T, Goaham H, Yoshida K, et al. Am J Pathol,1996; 149(3): 873-882.
  • 5Lukas J, Gao D Q, Keshmeshian M, et al. Cancer Res, 2001; 61(7): 3212-3219.
  • 6Iwase H, Omoto Y, Iwata H, et al. Oncology, 1998;55(1): 11-16.
  • 7Goedert M, Ghetti B, Spillantini M G. Ann N YAcad Sci, 2000; 920: 74-83.
  • 8Tapiola T. Neurology, 1998; 50: 169-184.
  • 9Spillantini M G, Van Swieten J C, Goedert M. Neurogenetics, 2000; 2(4): 193-205.
  • 10Ishizawa K, Ksiezak-Reding H, Davies P, et al. Acta Neuropathol (Berl), 2000; 100(3): 235-244.

同被引文献44

  • 1林鲁萍,马飞,王义权.基因选择性剪接的生物信息学研究概况[J].遗传,2005,27(6):1001-1006. 被引量:6
  • 2左持鞅.医学生物学[M].北京:人民卫生出版社,2001.5-7.
  • 3G.H.弗里德 G.J.黑德莫诺斯著 田清涞等译.生物学[M].北京: 科学出版社, 麦格劳-希尔教育出版集团,2002.183~190.
  • 4RM特怀曼著 陈淳译.高级分子生物学要义[M].北京:科学出版社,2001..
  • 5Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet, 2002, 30 : 13-19.
  • 6de The H, Lavau C, Marcio A, et al. The PML-RAR alpha fusion mRNA generated by the t( 15 ; 17 ) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 1991,66: 675 -684.
  • 7Graveley BR. Alternative splicing: increasing diversity in the proteomic world. Trends Genet, 2001,17 : 100-107.
  • 8Veuger M J, Honders MW, Landegent JE, et al. High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia. Blood, 2000, 96 : 1517-1524.
  • 9Renshaw J, Orr RM, Walton ML, et al. Disruption of WTI gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival. Mol Cancer Ther,2004,3 : 1467-1483.
  • 10Stamma S, Ben-Ari S, Rafalska I, et al. Function of allernative splicing [J]. Gene, 2005, 344:1 - 20.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部